Cyanocobalamin
Brand names: Cytacon
Cyanocobalamin is a form of vitamin B12 used to treat and prevent vitamin B12 deficiency.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is converted in the body to the active coenzymes methylcobalamin and adenosylcobalamin, which are required for DNA synthesis and normal red cell and neuronal function.
Prescribing in practice
- In deficiency with neurological involvement or pernicious anaemia, parenteral hydroxocobalamin is generally preferred, as oral cyanocobalamin relies on adequate absorption.
- Identify and address the underlying cause of deficiency rather than treating the blood result alone.
- Correcting B12 deficiency can unmask or precipitate hypokalaemia as haematopoiesis recovers.
Monitoring
Monitor the haematological response and serum potassium during initial correction of significant deficiency.
Counselling the patient
- Lifelong treatment may be needed if the cause of deficiency is permanent, such as pernicious anaemia.
- Tell your team if you follow a vegan diet or have had gastrointestinal surgery, as these affect B12.
- Take oral preparations as directed and report return of symptoms such as fatigue or tingling.
Evidence & guidelines
Use of vitamin B12 replacement in deficiency is long-established standard practice; consult current prescribing references on choice of preparation and route.
Reference: NICE CKS; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Splenomegaly Workup · BSH; BMJ Best Practice
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO